Shared compound evidence record
Tesamorelin (10mg)
Weight Management
In Stock
Tesamorelin
20mg Lyophilised Powder
Tesamorelin 20mg is supplied as lyophilised powder in a research vial. Compare the current Australian catalogue price, availability and analytical-document status on this page. The 20 mg label describes the nominal quantity per vial, not a solution concentration. For laboratory research only; not for human or veterinary use.
$259.99AUD per vial
1
1 vial · Item total$259.99 AUD
Free express shipping Australia-wide
No account needed. PayID or bank transfer instructions follow checkout.
Labelled quantity
20mg
Category
Weight Management
Volume Savings
No published analytical document is currently linked
Availability
Ready to purchase now
In stock now and ready for checkout.
Same-day dispatch cutoff
Order within the current dispatch window
Melbourne cut-off time updates live every second.
Time Remaining
05:27:56
Frequently Bought Together
Stable research navigation
Connected catalogue records
These links are based on catalogue family, evidence records, research topics and bundle composition. They do not imply therapeutic similarity.
Connected compound evidence
CJC-1295 (no DAC) (10mg)
Performance & Recovery
Connected compound evidence
CJC-1295 (no DAC) + Ipamorelin (10mg)
Performance & Recovery
Connected compound evidence
Tirzepatide (20mg)
Weight Management
Connected compound evidence
CJC-1295 with DAC (10mg)
Performance & Recovery
Connected compound evidence
Tirzepatide (40mg)
Weight Management
Research library
Evidence and analytical context for this record
These resources separate compound identity, batch-quality questions and study evidence. A linked study does not establish that this catalogue material is equivalent to a medicine or investigational product.
Product Information
Tesamorelin 20mg research vial
This listing describes Tesamorelin (20mg), supplied as lyophilised powder for laboratory research. Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue. The displayed price is for one vial; check the current stock or pre-order status on this page.
Understand the vial quantity
The 20mg label states the nominal quantity per vial. It is not a solution concentration, a measured purity result or a human-use instruction. Compare the exact presentation and documentation when assessing the Tesamorelin 10mg listing and this 20mg vial.
Check the analytical-document status
Use the document status shown on this page and the CoA library to find available records. Check the compound, vial quantity, batch identifier and reported methods. A report for a different presentation or batch does not establish the identity, content, purity or sterility of this vial. Request missing documentation before relying on a claim.
Read the evidence in context
The Tesamorelin research guide links the relevant studies and explains their population and formulation limits. Evidence from a pharmaceutical study does not establish equivalence of separately sourced research material.
Laboratory handling and intended use
Use documented material-specific storage conditions and your laboratory's validated preparation method. The storage guide explains which conditions and records to check; a generic shelf life cannot establish stability for a particular solution.
For laboratory research only. Not for human or veterinary use. Refer to the shipping information for current dispatch terms.
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue. This listing is for a laboratory research material. The Tesamorelin research guide explains the compound classification and the limits of the published evidence.
What form is Tesamorelin 20mg supplied in for Australian research?
Tesamorelin (20mg) is supplied as lyophilised powder in a research vial. It is listed for controlled laboratory research only, not as a prescription medicine, pre-filled device or product for human use.
What does the 20mg vial label mean?
It describes the nominal quantity in one vial. It is not a solution concentration or a measurement of batch purity. Check the matching analytical record for any measured content or purity result.
What does the published Tesamorelin research establish?
A randomised placebo-controlled study investigated a specific formulation in people with HIV-associated abdominal fat accumulation. Its findings should not be generalised to other populations or used to claim that this research vial is equivalent to the studied product.
How do I compare Tesamorelin 10mg and 20mg research vials?
Compare the nominal quantity, current price, availability and documentation for each exact listing. The 10mg presentation and this 20mg presentation have separate catalogue records. A report for one presentation does not automatically cover the other.
What analytical documents should I check before ordering?
Check this page's document status and the CoA library. Confirm that the compound, vial quantity and batch identifiers match the material being assessed, and distinguish identity, measured content and purity. If a matching report is pending, request it rather than relying on a report for another product.
What is the availability and price of Tesamorelin 20mg in Australia?
Tesamorelin (20mg) is currently in stock at AUS Peptide Supply and available for domestic dispatch across Australia. Tesamorelin (20mg) is priced at $259.99 AUD per vial at AUS Peptide Supply. Check this page's analytical-document status and the CoA library for published records.
How should a laboratory confirm storage and preparation conditions?
Use the material-specific documentation and a validated laboratory method. Record the solvent, preparation date and storage conditions; do not assume one shelf life applies to every solution. See the storage guide and laboratory preparation guide.